A Missouri judge approved Bayer's $7.25 billion settlement Friday to resolve thousands of lawsuits from cancer patients who claim the company's Roundup weedkiller caused non-Hodgkin lymphoma, marking one of the largest class recoveries in U.S. history.
St. Louis Circuit Judge Timothy Boyer said in his ruling that individual payouts are "fair and adequate" and the total amount is "among the largest in the history of mass tort personal-injury class action settlements." The settlement applies to Roundup users already diagnosed with the cancer and those who become ill in future years.
Participants could receive an average of between $10,000 and $165,000 depending on product use, age at diagnosis and illness severity. Agricultural, industrial or turf workers exposed at length to Roundup could get an average of $165,000 if diagnosed with an aggressive form before age 60, while anyone diagnosed at 78 or older would receive significantly less, averaging $10,000.
Bayer will make annual payments into a special fund for up to 21 years under the settlement, which was proposed in February. The agreement includes $600 million for attorneys' fees. Judge Boyer said there was a risk Bayer would have filed for bankruptcy if the settlement had been rejected.
For Germany-based Bayer, which denies Roundup causes cancer, the settlement provides financial certainty against mounting litigation costs that led the company to consider pulling the product from U.S. agricultural markets. Bayer has already changed the formula for Roundup sold to residential users and removed glyphosate, the weedkiller's active ingredient, from new residential versions.
The settlement came after the U.S. Supreme Court ruled in June that Bayer cannot be sued in state courts on failure-to-warn claims because federal regulations do not require a cancer warning label and states are forbidden from imposing additional labeling requirements. That ruling had undercut one of the central arguments in the lawsuits.
About 200,000 Roundup-related claims have been made against Bayer, many from people who used it on residential lawns and gardens. Monsanto, a Missouri-based company, debuted Roundup in 1974. Bayer acquired Monsanto in 2018 along with the growing litigation.
The World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic" in 2015. The U.S. Environmental Protection Agency has determined it is not likely to cause cancer in humans when used as directed.
Some attorneys for cancer patients contend the settlement payouts are too small. Attorney Gerson Smoger said during a September court hearing that the settlement "locked in future claimants for decades with no chance at punitive damages" while "kept the product that they were exposed to on the market, allowing the victims to continue to be exposed." Other attorneys argue the deal is better than the heightened likelihood of getting nothing after the Supreme Court ruling.
Bayer CEO Bill Anderson said the court-approved settlement is "a decisive milestone in the company's strategy to mitigate the risks of both pending and future Roundup litigation." The decision could be appealed. Bayer previously set aside $16 billion to cover legal costs related to Roundup cases.